BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 32594384)

  • 1. Computed Tomography and Magnetic Resonance Imaging.
    Bernsen MR; van Straten M; Kotek G; Warnert EAH; Haeck JC; Ruggiero A; Wielopolski PA; Krestin GP
    Recent Results Cancer Res; 2020; 216():31-110. PubMed ID: 32594384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computed tomography and magnetic resonance imaging.
    Bernsen MR; Ruggiero A; van Straten M; Kotek G; Haeck JC; Wielopolski PA; Krestin GP
    Recent Results Cancer Res; 2013; 187():3-63. PubMed ID: 23179877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole-body magnetic resonance imaging and positron emission tomography-computed tomography in oncology.
    Schmidt GP; Kramer H; Reiser MF; Glaser C
    Top Magn Reson Imaging; 2007 Jun; 18(3):193-202. PubMed ID: 17762383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PET in oncology: will it replace the other modalities?
    Hoh CK; Schiepers C; Seltzer MA; Gambhir SS; Silverman DH; Czernin J; Maddahi J; Phelps ME
    Semin Nucl Med; 1997 Apr; 27(2):94-106. PubMed ID: 9144854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imaging for Response Assessment in Radiation Oncology: Current and Emerging Techniques.
    Stieb S; Kiser K; van Dijk L; Livingstone NR; Elhalawani H; Elgohari B; McDonald B; Ventura J; Mohamed ASR; Fuller CD
    Hematol Oncol Clin North Am; 2020 Feb; 34(1):293-306. PubMed ID: 31739950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From PET/CT to PET/MRI: advances in instrumentation and clinical applications.
    Hu Z; Yang W; Liu H; Wang K; Bao C; Song T; Wang J; Tian J
    Mol Pharm; 2014 Nov; 11(11):3798-809. PubMed ID: 25058336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncologic imaging end-points for the assessment of therapy response.
    Serkova NJ; Garg K; Bradshaw-Pierce EL
    Recent Pat Anticancer Drug Discov; 2009 Jan; 4(1):36-53. PubMed ID: 19149687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What scans we will read: imaging instrumentation trends in clinical oncology.
    Beyer T; Bidaut L; Dickson J; Kachelriess M; Kiessling F; Leitgeb R; Ma J; Shiyam Sundar LK; Theek B; Mawlawi O
    Cancer Imaging; 2020 Jun; 20(1):38. PubMed ID: 32517801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Image correlation in oncology.
    Chen GT; Pelizzari CA; Levin DN
    Important Adv Oncol; 1990; ():131-41. PubMed ID: 2182516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positron Emission Tomography/Magnetic Resonance Imaging for Local Tumor Staging in Patients With Primary Breast Cancer: A Comparison With Positron Emission Tomography/Computed Tomography and Magnetic Resonance Imaging.
    Grueneisen J; Nagarajah J; Buchbender C; Hoffmann O; Schaarschmidt BM; Poeppel T; Forsting M; Quick HH; Umutlu L; Kinner S
    Invest Radiol; 2015 Aug; 50(8):505-13. PubMed ID: 26115367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modern techniques in radiological imaging related to oncology.
    Gwyther SJ
    Ann Oncol; 1994; 5 Suppl 4():3-7. PubMed ID: 8060895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncologic imaging: interactions of nuclear medicine with CT and MRI using the bone scan as a model.
    Tryciecky EW; Gottschalk A; Ludema K
    Semin Nucl Med; 1997 Apr; 27(2):142-51. PubMed ID: 9144856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Options for visualizing metastatic disease in the living body.
    Helms MW; Brandt BH; Contag CH
    Contrib Microbiol; 2006; 13():209-231. PubMed ID: 16627968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positron emission tomography/magnetic resonance imaging (PET/MRI): An update and initial experience at HC-FMUSP.
    Queiroz MA; Barbosa FG; Buchpiguel CA; Cerri GG
    Rev Assoc Med Bras (1992); 2018 Jan; 64(1):71-84. PubMed ID: 29561945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whole-body PET/MRI: the future in oncological imaging.
    Seemann MD
    Technol Cancer Res Treat; 2005 Oct; 4(5):577-82. PubMed ID: 16173829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Image-guided cancer therapy using PET/CT.
    Yap JT; Carney JP; Hall NC; Townsend DW
    Cancer J; 2004; 10(4):221-33. PubMed ID: 15383203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hybrid Imaging in Oncology.
    Fatima N; Zaman Mu; Gnanasegaran G; Zaman U; Shahid W; Zaman A; Tahseen R
    Asian Pac J Cancer Prev; 2015; 16(14):5599-605. PubMed ID: 26320423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Continuing Evolution of Molecular Functional Imaging in Clinical Oncology: The Road to Precision Medicine and Radiogenomics (Part I).
    Vaidya T; Agrawal A; Mahajan S; Thakur MH; Mahajan A
    Mol Diagn Ther; 2019 Feb; 23(1):1-26. PubMed ID: 30411216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Continuing Evolution of Molecular Functional Imaging in Clinical Oncology: The Road to Precision Medicine and Radiogenomics (Part II).
    Vaidya T; Agrawal A; Mahajan S; Thakur MH; Mahajan A
    Mol Diagn Ther; 2019 Feb; 23(1):27-51. PubMed ID: 30387041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The growing development of multimodality imaging in oncology.
    Papathanassiou D; Liehn JC
    Crit Rev Oncol Hematol; 2008 Oct; 68(1):60-5. PubMed ID: 18765183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.